NCT05737212 2025-02-21Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade GliomasDawonmedax Co., Ltd.Phase 1/2 Terminated7 enrolled
NCT03649464 2022-10-07Investigation of Oral OKN-007 in Recurrent High-grade Glioma ParticipantsOblato, Inc.Phase 1/2 Withdrawn
NCT00683761 2009-07-17A Study of 131I-TM601 in Adults With Recurrent Malignant GliomaTransMolecularPhase 1/2 Unknown64 enrolled